SCHEMBL15818754

SCHEMBL15818754

COc1ccc2nc(C3CC3)nc(N3CCN(c4ccccc4OC)CC3)c2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
NTSR1 P30989 20/20 1.00
HTR1A P08908 1/20 0.78
TSPO P30536 1/20 0.78
HTR7 P34969 1/20 0.78
HRH1 P35367 1/20 0.78
OPRM1 P35372 1/20 0.78
HTR3A P46098 1/20 0.78
SIGMAR1 Q99720 1/20 0.78
ALDH1A1 P00352 1/20 0.72
MAPT P10636 1/20 0.72
PAX8 Q06710 1/20 0.72
L3MBTL1 Q9Y468 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15819562 0.96 NTSR1 (1.00) NTSR1HTR1ATSPOHTR7HRH1
SCHEMBL19519254 0.89 NTSR1 (0.81) NTSR1HTR1ATSPOHTR7HRH1
SCHEMBL15820890 0.88 NTSR1 (0.79) NTSR1HTR1ATSPOHTR7HRH1
SCHEMBL15819897 0.88 NTSR1 (0.79) NTSR1HTR1ATSPOHTR7HRH1
SCHEMBL15819587 0.88 NTSR1 (1.00) NTSR1HTR1ATSPOHTR7HRH1
SCHEMBL29395526 0.88 NTSR1 (1.00) NTSR1HTR1ATSPOHTR7HRH1
SCHEMBL15819160 0.88 NTSR1 (0.91) NTSR1HTR1ATSPOHTR7HRH1
SCHEMBL15819273 0.88 NTSR1 (1.00) NTSR1HTR1ATSPOHTR7HRH1
SCHEMBL15820524 0.87 NTSR1 (0.76) NTSR1HTR1ATSPOHTR7HRH1
SCHEMBL15834199 0.87 NTSR1 (0.76) NTSR1HTR1ATSPOHTR7HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2938608-B1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 SANFORD BURNHAM MED RES INST (US) 2021-08-04 EP claimed
US-9868707-B2 Small molecule agonists of neurotensin receptor 1 SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2018-01-16 US claimed
US-20150329497-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 DUKE UNIVERSITY (US) 2015-11-19 US claimed
EP-2938608-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 Sanford-Burnham Medical Research Institute (US) 2015-11-04 EP claimed
WO-2014100501-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2014-06-26 WO claimed
EP-2938608-B1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 SANFORD BURNHAM MED RES INST (US) 2021-08-04 EP disclosed
US-9868707-B2 Small molecule agonists of neurotensin receptor 1 SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2018-01-16 US disclosed
US-20150329497-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 DUKE UNIVERSITY (US) 2015-11-19 US disclosed
EP-2938608-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 Sanford-Burnham Medical Research Institute (US) 2015-11-04 EP disclosed
WO-2014100501-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2014-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150329497-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 NTSR1, NTSR2, VIPR1 NTSR1 1/4885HTR1A 116/4885TSPO 784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.